Army Hospital R&R Performs First Robotic Stereotactic Brain Stem Biopsy
In a landmark achievement for military medicine, the Neurosurgery Department at the Army Hospital Research & Referral (R&R) has successfully performed the first-ever robotic...
Vertex to Acquire Crinetics Pharmaceuticals for $10.0 Billion, Expanding Rare Endocrine Disease Portfolio
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. announced a definitive agreement under which Vertex will acquire Crinetics for $85.00 per share in...
World’s First Once-Weekly Basal Insulin Now in India as Novo Nordisk Launches Awiqli®
In a major milestone for diabetes management, India has become one of the first countries globally to introduce Awiqli, the world’s first once-a-week basal insulin...
Rajasthan Recalls Labour-Inducing Gel Over Quality Test Failure
Rajasthan's Drug Control Department has ordered an immediate recall of a specific batch of Dinoprostone Gel, a critical drug commonly used to induce labour and soften...
FDA Grants Accelerated Approval to Vera Therapeutics’ TRUTAKNA™️ for Primary IgA Nephropathy
Vera Therapeutics, Inc. (Nasdaq: VERA) announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to TRUTAKNA™ (atacicept-vymj). The therapy is...
Cadila Pharmaceuticals and Wellesta Holdings Ink JV to Expand Healthcare Reach in South-East Asia
Cadila Pharmaceuticals, a leading Indian integrated pharma major, has entered into a Memorandum of Understanding with Singapore-based WellestaHoldings Pte. Ltd. to form a joint venture targeting expanded healthcare...